Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Med Chem ; 23(21): 2275-85, 2016.
Article in English | MEDLINE | ID: mdl-27237817

ABSTRACT

Pompe disease or glycogen storage disease type II (OMIM: 232300) is a lysosomal storage disorder resulting from a partial or total lack of acid alphaglucosidase, which may produce muscle weakness, gait abnormalities, or even death by respiratory failure. In the last decade, autophagy has been proposed as a mechanism involved in the severity of symptoms related to this disorder and as a potential therapeutic target to alleviate disease progression. This review summarizes the relationship between autophagy and Pompe disease, including what information has been recently discovered and what remains unclear.


Subject(s)
Autophagy , Glycogen Storage Disease Type II/pathology , Animals , Disease Models, Animal , Enzyme Replacement Therapy , Glycogen Storage Disease Type II/metabolism , Glycogen Storage Disease Type II/therapy , Humans , Microtubule-Associated Proteins/metabolism , Mitochondria/metabolism , Muscle, Skeletal/metabolism , alpha-Glucosidases/genetics , alpha-Glucosidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...